Serveur d'exploration Covid (26 mars)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

[Chemotherapy strategy for colorectal cancer under the outbreak of corona virus disease 2019].

Identifieur interne : 000035 ( new/Analysis ); précédent : 000034; suivant : 000036

[Chemotherapy strategy for colorectal cancer under the outbreak of corona virus disease 2019].

Auteurs : Y H Li [République populaire de Chine] ; L. Shen ; J. Li

Source :

RBID : pubmed:32192297

Descripteurs français

English descriptors

Abstract

The outbreak of corona virus disease 2019 (COVID-19) makes the medical treatment of colorectal cancers difficult. Cancer patients are more susceptible to infection and tumor history is defined as an important factor of poor prognosis, which challenges both doctors and patients. For metastatic colorectal cancer (CRC) patients, maintenance therapy is the optimal choice. The patients with tumor progression or poor biological behavior should receive or continue combination chemotherapy. Adjuvant chemotherapy should reduce the intensity of treatment and shorten the therapy time. Fever patients during chemotherapy need to receive differential diagnosis and screening according to national standards. Patients with stable diseases and good general conditions may delay imaging examination. Clinicians should make individual clinical decisions based on the specifics of each patient during epidemic situation.

DOI: 10.3760/cma.j.cn.441530-20200225-00089
PubMed: 32192297


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:32192297

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">[Chemotherapy strategy for colorectal cancer under the outbreak of corona virus disease 2019].</title>
<author>
<name sortKey="Li, Y H" sort="Li, Y H" uniqKey="Li Y" first="Y H" last="Li">Y H Li</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Gastrointestinal Cancer, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Bejing 100142, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Gastrointestinal Cancer, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Bejing 100142</wicri:regionArea>
<wicri:noRegion>Bejing 100142</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Shen, L" sort="Shen, L" uniqKey="Shen L" first="L" last="Shen">L. Shen</name>
</author>
<author>
<name sortKey="Li, J" sort="Li, J" uniqKey="Li J" first="J" last="Li">J. Li</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32192297</idno>
<idno type="pmid">32192297</idno>
<idno type="doi">10.3760/cma.j.cn.441530-20200225-00089</idno>
<idno type="wicri:Area/PubMed/Corpus">000282</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000282</idno>
<idno type="wicri:Area/PubMed/Curation">000282</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000282</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000107</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000107</idno>
<idno type="wicri:Area/Ncbi/Merge">001320</idno>
<idno type="wicri:Area/Ncbi/Curation">001320</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001320</idno>
<idno type="wicri:doubleKey">1671-0274:2020:Li Y:chemotherapy:strategy:for</idno>
<idno type="wicri:Area/Main/Merge">000114</idno>
<idno type="wicri:Area/Main/Curation">000112</idno>
<idno type="wicri:Area/Main/Exploration">000112</idno>
<idno type="wicri:Area/new/Extraction">000035</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">[Chemotherapy strategy for colorectal cancer under the outbreak of corona virus disease 2019].</title>
<author>
<name sortKey="Li, Y H" sort="Li, Y H" uniqKey="Li Y" first="Y H" last="Li">Y H Li</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Gastrointestinal Cancer, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Bejing 100142, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Gastrointestinal Cancer, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Bejing 100142</wicri:regionArea>
<wicri:noRegion>Bejing 100142</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Shen, L" sort="Shen, L" uniqKey="Shen L" first="L" last="Shen">L. Shen</name>
</author>
<author>
<name sortKey="Li, J" sort="Li, J" uniqKey="Li J" first="J" last="Li">J. Li</name>
</author>
</analytic>
<series>
<title level="j">Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery</title>
<idno type="ISSN">1671-0274</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antineoplastic Combined Chemotherapy Protocols</term>
<term>Chemotherapy, Adjuvant</term>
<term>Colorectal Neoplasms (complications)</term>
<term>Colorectal Neoplasms (drug therapy)</term>
<term>Coronavirus Infections (complications)</term>
<term>Disease Outbreaks</term>
<term>Humans</term>
<term>Pneumonia, Viral (complications)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Flambées de maladies</term>
<term>Humains</term>
<term>Infections à coronavirus ()</term>
<term>Pneumopathie virale ()</term>
<term>Protocoles de polychimiothérapie antinéoplasique</term>
<term>Traitement médicamenteux adjuvant</term>
<term>Tumeurs colorectales ()</term>
<term>Tumeurs colorectales (traitement médicamenteux)</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Colorectal Neoplasms</term>
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Colorectal Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Tumeurs colorectales</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Antineoplastic Combined Chemotherapy Protocols</term>
<term>Chemotherapy, Adjuvant</term>
<term>Disease Outbreaks</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Flambées de maladies</term>
<term>Humains</term>
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Protocoles de polychimiothérapie antinéoplasique</term>
<term>Traitement médicamenteux adjuvant</term>
<term>Tumeurs colorectales</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The outbreak of corona virus disease 2019 (COVID-19) makes the medical treatment of colorectal cancers difficult. Cancer patients are more susceptible to infection and tumor history is defined as an important factor of poor prognosis, which challenges both doctors and patients. For metastatic colorectal cancer (CRC) patients, maintenance therapy is the optimal choice. The patients with tumor progression or poor biological behavior should receive or continue combination chemotherapy. Adjuvant chemotherapy should reduce the intensity of treatment and shorten the therapy time. Fever patients during chemotherapy need to receive differential diagnosis and screening according to national standards. Patients with stable diseases and good general conditions may delay imaging examination. Clinicians should make individual clinical decisions based on the specifics of each patient during epidemic situation.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>République populaire de Chine</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Li, J" sort="Li, J" uniqKey="Li J" first="J" last="Li">J. Li</name>
<name sortKey="Shen, L" sort="Shen, L" uniqKey="Shen L" first="L" last="Shen">L. Shen</name>
</noCountry>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="Li, Y H" sort="Li, Y H" uniqKey="Li Y" first="Y H" last="Li">Y H Li</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/new/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000035 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/new/Analysis/biblio.hfd -nk 000035 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    new
   |étape=   Analysis
   |type=    RBID
   |clé=     pubmed:32192297
   |texte=   [Chemotherapy strategy for colorectal cancer under the outbreak of corona virus disease 2019].
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/new/Analysis/RBID.i   -Sk "pubmed:32192297" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/new/Analysis/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidV2 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021